Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin injection for weight loss in obesity
IRCT20250108064319N1Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Feb 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of neuronox in obesity and Overweight, sponsored by Hormozgan University of Medical Sciences. Started Feb 2025; status: completed.
02
Drugs
neuronox
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on IRCT20250108064319N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250108064319N1.